USPTO serial 79395860
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Fraser
Jennifer Fraser Dykema Gossett PLLC1301 K Street, NW, Suite 1100 WestWashington, DC 20005United States| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological research and design services, namely, development and planning of manufacturing processes for the production of vitamins, food supplements for humans and animals, bio pesticides and chemicals; biotechnological and pharmaceutical research; consultancy related to biotechnology; development in the field of biotechnology and pharmaceuticals; engineering; scientific research in the field of genetics and genetic engineering; biological cloning services; development and research in the field of microbial biotechnology; scientific and technological research, development and testing services in the field of biotechnology, biochemistry, microbiology and molecular science; biological research, clinical research in the fields of genetic studies and medical research; industrial analysis of bioproducts and research in the field of bioproduction; research and development of industrial process; chemical technological research; development of new technologies for others in the field of pharmaceutical, chemical and agri-food industries; product development for others; design of production methods; custom development of new chemical and biological strains for use in the chemical, pharmaceutical, and agriculture industries; custom development of new genes, proteins and protein fractions for use in chemistry, pharmaceuticals, agriculture, diagnostics, medicine and industry; algorithm-supported custom design and development of chemical and biological strains and fermentation media; testing, authentication and quality control of molecules for others in the field of microscopy; biological research laboratory services; vaccine development and testing; monitoring, controlling, assessing and consulting with reference to biohazards for scientific research purposes; biological, microbiological, pathogenic and viral screening and testing services for scientific research purposes; collecting, maintaining and providing access to bacterial cultures and bacterial isolates for scientific and research purposes; pharmaceutical research; analysis and developments in the field of molecular biology for scientific research purposes; biomedical research services; DNA sequencing for medical research purposes; scientific laboratory services, namely, preparation of biological samples for analysis in research laboratories; research services in the field of proteins, antibodies, microorganisms and cells; development of pharmaceutical preparations, medicines, biological molecules, stem cells, genes, vaccines, bacteria, viruses; scientific and technological research and design services, namely, development of final downstream processing in the production of microbial production strains in the field of pharmacy, biotechnology, genetics, biochemistry, microbiology and molecular sciences; research services in the field of cell separation and pharmaceutical drug purification; scientific laboratory services related to the isolation and cultivation of human tissues and cells; scientific laboratory services, namely, preparation of biological samples for research purposes. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 31, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 30, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 24, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 24, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 24, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 3, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 3, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 28, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 13, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 31, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 15, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 15, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 1, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 1, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 1, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 9, 2025 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 3, 2025 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 10, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 23, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 4, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 4, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 30, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 22, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 16, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |